The Indian pharmaceuticals market has characteristics that make it unique. Indian pharmaceuticals market will grow to USD 55 billion by 2020 driven by a steady increase in affordability and a step jump in market access. If we compare Pharmaceutical industry in India according to their regions then, South India is emerging as a strong Pharma hub with a vibrant IT industry and a strong infrastructure of research facilities and scientists. Bengaluru, Hyderabad and Chennai are being viewed as important in sourcing center.

Hyderabad has a dominant position in Pharma Sector, it ranks first in the manufacturing of bulk drugs and third in formulations in the country. It accounts for 40 percent of the total Indian bulk drug production and 50 percent of the bulk drug exports and is considered as the ‘Bulk Drug Capital of India’. In value terms, the industry is worth US$ 1.6 billion and exports accounting to over US$ 500 million. The Pharma industry and exports from here are expected to grow at 20 per cent annually.

This welcomes the Indian Pharma players to venture and capitalize the opportunities. We at UBM India are giving you an opportunity to meet industry experts at a single platform. The 4th edition of PharmaLytica is here with a number of value-added attractions, which will make your visit to the event worthwhile.
Why Visit Pharmalytica 2018